Nektar Therapeutics (NKTR): Price and Financial Metrics

Nektar Therapeutics (NKTR): $1.48

0.02 (+1.37%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add NKTR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#59 of 341

in industry

NKTR Price/Volume Stats

Current price $1.48 52-week high $1.93
Prev. close $1.46 52-week low $0.41
Day low $1.43 Volume 724,900
Day high $1.50 Avg. volume 2,082,114
50-day MA $1.39 Dividend yield N/A
200-day MA $0.91 Market Cap 272.35M

NKTR Stock Price Chart Interactive Chart >


Nektar Therapeutics (NKTR) Company Bio


Nektar Therapeutics is a biopharmaceutical company, developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives, and immunology.


NKTR Latest News Stream


Event/Time News Detail
Loading, please wait...

NKTR Latest Social Stream


Loading social stream, please wait...

View Full NKTR Social Stream

Latest NKTR News From Around the Web

Below are the latest news stories about NEKTAR THERAPEUTICS that investors may wish to consider to help them evaluate NKTR as an investment opportunity.

Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting

Nektar Therapeutics (NASDAQ:NKTR) announced that collaborators from the Cairo Laboratory at New York Medical College presented a poster highlighting new preclinical data on NKTR-255 at the 65th American Society of Hematology (ASH) Annual Meeting demonstrating that NKTR-255 significantly enhanced the cytotoxicity of expanded Natural Killer (NK) cells when combined with obinutuzumab against rituximab-resistant BL cells and significantly improved the survival of mice xenografted with Raji-4RH compa

Yahoo | December 11, 2023

Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 8, 2023

Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?

Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 7, 2023

Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript November 7, 2023 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $-0.18. Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that today’s conference is […]

Yahoo | November 9, 2023

Nektar Therapeutics (NKTR) Incurs Wider-Than-Expected Q3 Loss

Nektar (NKTR) misses third-quarter estimates for the bottom line but beats the same for the top line.

Yahoo | November 8, 2023

Read More 'NKTR' Stories Here

NKTR Price Returns

1-mo 26.50%
3-mo 12.12%
6-mo 190.77%
1-year 186.71%
3-year -91.04%
5-year -95.24%
YTD 161.95%
2023 -75.00%
2022 -83.27%
2021 -20.53%
2020 -21.24%
2019 -34.33%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!